Nemes Rush Group’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.74M | Buy |
14,780
+11,440
| +343% | +$2.12M | 0.3% | 62 |
|
|
2025
Q1 | $700K | Sell |
3,340
-378
| -10% | -$79.2K | 0.09% | 106 |
|
|
2024
Q4 | $661K | Sell |
3,718
-417
| -10% | -$74.1K | 0.08% | 108 |
|
|
2024
Q3 | $753K | Buy |
4,135
+244
| +6% | +$44.4K | 0.11% | 100 |
|
|
2024
Q2 | $667K | Sell |
3,891
-295
| -7% | -$50.6K | 0.09% | 105 |
|
|
2024
Q1 | $762K | Sell |
4,186
-96
| -2% | -$17.5K | 0.11% | 100 |
|
|
2023
Q4 | $664K | Sell |
4,282
-747
| -15% | -$116K | 0.11% | 112 |
|
|
2023
Q3 | $750K | Sell |
5,029
-1,663
| -25% | -$248K | 0.14% | 101 |
|
|
2023
Q2 | $902K | Buy |
+6,692
| New | +$902K | 0.16% | 90 |
|